Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHOE
4801
Shoe Station Group
SHOE
$414M
| $2.99M | ﹤0.01% |
+90,389
| New | +$3.27M |
|
4802
PUT
Red Cat Holdings
RCAT
$1.7B
| $2.99M | ﹤0.01% |
232,500
+168,100
| +261% | +$1.03M |
|
4803
CALL
Texas Pacific Land
TPL
$24.7B
| $2.99M | ﹤0.01% |
+8,100
| New | +$3.31M |
|
4804
CALL
United Natural Foods
UNFI
$2.93B
| $2.98M | ﹤0.01% |
109,300
-130,100
| -54% | -$3M |
|
4805
PUT
EVgo
EVGO
$519M
| $2.98M | ﹤0.01% |
735,600
+489,600
| +199% | +$3.11M |
|
4806
PUT
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$740M
| $2.98M | ﹤0.01% |
57,200
+40,100
| +235% | +$2.2M |
|
4807
GCM Grosvenor
GCMG
$2.81B
| $2.98M | ﹤0.01% |
242,708
+7,556
| +3% | +$89.8K |
|
4808
PUT
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
| $2.98M | ﹤0.01% |
42,520
+35,800
| +533% | +$2.56M |
|
4809
PUT
ProShares UltraShort Real Estate
SRS
$15.6M
| $2.98M | ﹤0.01% |
57,275
+56,250
| +5,488% | +$2.67M |
|
4810
CALL
Global X Copper Miners ETF NEW
COPX
$7.98B
| $2.97M | ﹤0.01% |
77,900
-80,000
| -51% | -$3.46M |
|
4811
CALL
Waters Corp
WAT
$40.5B
| $2.97M | ﹤0.01% |
8,000
-20,500
| -72% | -$7.5M |
|
4812
PUT
Frontline
FRO
$9.17B
| $2.97M | ﹤0.01% |
209,100
+105,400
| +102% | +$1.97M |
|
|
SKYT
4813
DELISTED
SkyWater Technology
SKYT
| $2.97M | ﹤0.01% |
215,008
+119,219
| +124% | +$1.18M |
|
4814
Lionsgate Studios
LION
$3.57B
| $2.97M | ﹤0.01% |
390,364
+361,717
| +1,263% | +$2.51M |
|
4815
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $2.96M | ﹤0.01% |
40,880
-7,030
| -15% | -$430K |
|
4816
Stratasys
SSYS
$781M
| $2.96M | ﹤0.01% |
+333,220
| New | +$2.87M |
|
4817
CALL
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $2.96M | ﹤0.01% |
53,400
-119,500
| -69% | -$6.82M |
|
4818
Theravance Biopharma
TBPH
$881M
| $2.96M | ﹤0.01% |
314,622
+80,066
| +34% | +$729K |
|
4819
Newmark Group
NMRK
$2.76B
| $2.96M | ﹤0.01% |
231,081
+191,470
| +483% | +$2.83M |
|
|
PRMB
4820
CALL
Primo Brands
PRMB
$8.94B
| $2.96M | ﹤0.01% |
+96,200
| New | +$2.85M |
|
|
UPB
4821
Upstream Bio Inc
UPB
$387M
| $2.96M | ﹤0.01% |
+180,000
| New | +$4.02M |
|
4822
CALL
Revolution Medicines
RVMD
$43.7B
| $2.96M | ﹤0.01% |
67,600
+56,900
| +532% | +$2.87M |
|
4823
Invesco Senior Loan ETF
BKLN
$6.76B
| $2.96M | ﹤0.01% |
140,297
-166,166
| -54% | -$3.5M |
|
4824
CNA Financial
CNA
$13.8B
| $2.96M | ﹤0.01% |
61,108
-91,349
| -60% | -$4.46M |
|
4825
Korn Ferry
KFY
$4.32B
| $2.95M | ﹤0.01% |
43,802
-38,888
| -47% | -$2.83M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.